» Articles » PMID: 23593937

Interplay Between Coagulation and Vascular Inflammation in Sickle Cell Disease

Overview
Journal Br J Haematol
Specialty Hematology
Date 2013 Apr 19
PMID 23593937
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Sickle cell disease is the most common inherited haematological disorder that leads to the irreversible damage of multiple organs. Although sickling of red blood cells and vaso-occlusion are central to the pathophysiology of sickle cell disease, the importance of haemolytic anaemia and vasculopathy has been recently recognized. A hypercoagulable state is another prominent feature of sickle cell disease and is mediated by activation of both intrinsic and extrinsic coagulation pathways. Growing evidence demonstrates that coagulation may not only contribute to the thrombotic complications, but also to vascular inflammation associated with this disease. This article summarizes the role of vascular inflammation and coagulation activation, discusses potential mechanisms responsible for activation of coagulation and reviews recent data demonstrating the crosstalk between coagulation and vascular inflammation in sickle cell disease.

Citing Articles

Non-invasive optical and laboratory hematologic biomarkers correlate in patients with sickle cell disease.

Quang T, Mostashari G, Berning E, Gopalan B, Lizarralde-Iragorri M, Lovins D Biomed Opt Express. 2024; 15(8):4829-4841.

PMID: 39346999 PMC: 11427197. DOI: 10.1364/BOE.527770.


Disease severity drives risk of venous thrombotic events in women with sickle cell disease in a single-center retrospective study.

Light J, Abrams C, Ilich A, Huang S, Zhu H, Baskin-Miller J Res Pract Thromb Haemost. 2024; 8(4):102471.

PMID: 39099800 PMC: 11295566. DOI: 10.1016/j.rpth.2024.102471.


A Compact Differential Dynamic Microscopy-based Device (cDDM): An Approach Tool for Early Detection of Hypercoagulable State in Transfusion-Dependent-β-Thalassemia Patients.

Petiwathayakorn T, Paradee N, Hantrakool S, Jarujareet U, Intharah T, Srichairatanakool S ACS Appl Bio Mater. 2024; 7(7):4710-4724.

PMID: 38920024 PMC: 11253095. DOI: 10.1021/acsabm.4c00516.


A Case of Sickle Cell Retinopathy With Retinal Artery Occlusion in African-Japanese Patients.

Kato Y, Kominami T Cureus. 2024; 16(5):e60653.

PMID: 38899256 PMC: 11185989. DOI: 10.7759/cureus.60653.


Platelet Aggregation Studies and Coagulation Profile in Sickle Cell Disease in Symptomatic and Steady State Patients.

Nagose V, Kodate P, Kumbhalkar D, Rathod S, Nayak S Indian J Hematol Blood Transfus. 2024; 40(2):281-288.

PMID: 38708151 PMC: 11065820. DOI: 10.1007/s12288-023-01703-9.


References
1.
Solovey A, Kollander R, Shet A, Milbauer L, Choong S, Panoskaltsis-Mortari A . Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood. 2004; 104(3):840-6. DOI: 10.1182/blood-2003-10-3719. View

2.
Roszell N, Danton M, Jiang M, Witte D, Daugherty C, Grimes T . Fibrinogen deficiency, but not plasminogen deficiency, increases mortality synergistically in combination with sickle hemoglobin SAD in transgenic mice. Am J Hematol. 2007; 82(12):1044-8. DOI: 10.1002/ajh.20982. View

3.
Trudel M, De Paepe M, Chretien N, Saadane N, Jacmain J, Sorette M . Sickle cell disease of transgenic SAD mice. Blood. 1994; 84(9):3189-97. View

4.
Gee B, Platt O . Sickle reticulocytes adhere to VCAM-1. Blood. 1995; 85(1):268-74. View

5.
Mohan J, Lip G, Wright J, Bareford D, Blann A . Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation. Blood Coagul Fibrinolysis. 2005; 16(3):209-14. DOI: 10.1097/01.mbc.0000164431.98169.8f. View